Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Open access
Collections
- Biomanguinhos - Artigos de Periódicos [450]
- ENSP - Artigos de Periódicos [2338]
- INI - Artigos de Periódicos [3466]
- IOC - Artigos de Periódicos [12658]
Metadata
Show full item record
ROTAVIRUS A SHEDDING AND HBGA HOST GENETIC SUSCEPTIBILITY IN A BIRTH COMMUNITY-COHORT, RIO DE JANEIRO, BRAZIL, 2014-2018
Histo-blood group antigen
Sequencing
Gastrointestinal diseases
Live attenuated vaccines
Author
Affilliation
Abstract
Recent studies have investigated whether the human histo-blood group antigen (HBGAs) could affect the effectiveness of the oral rotavirus vaccines, suggesting secretor positive individuals develop a more robust response. We investigated the Rotavirus A (RVA) shedding in association with the host susceptibility profile in children from a birth community-cohort in Rio de Janeiro, Brazil, from 2014 to 2018. A total of 132 children were followed-up between 0 to 11-month-old, stool samples were collected before/after the 1st/2nd RV1 vaccination doses and saliva samples were collected during the study. RVA shedding was screened by RT-qPCR and G/P genotypes determined by multiplex RT-PCR and/or Sanger nucleotide sequencing. The sequencing indicated an F167L amino acid change in the RV1 VP8* P[8] in 20.5% of shedding follow-ups and these mutant subpopulations were quantified by pyrosequencing. The HBGA/secretor status was determined and 80.3% of the children were secretors. Twenty-one FUT2 gene SNPs were identified and two new mutations were observed. The mutant F167L RV1 VP8* P[8] was detected significantly more in Le (a+b+) secretors (90.5%) compared to non-secretors and even to secretors Le (a-b+) (9.5%). The study highlights the probable association between RV1 shedding and HBGAs as a marker for evaluating vaccine strain host susceptibility.
Keywords
Rotavirus AHisto-blood group antigen
Sequencing
Gastrointestinal diseases
Live attenuated vaccines
Share